期刊文献+

探讨Lys-C胰蛋白酶对于质谱法测定糖化血红蛋白的应用价值 被引量:1

Application value of Lys-C trypsin for the detection of HbA1c by using mass spectrometric method*
下载PDF
导出
摘要 目的探讨Lys-C胰蛋白酶在国际临床化学组织(International Federation of Clinical Chemistry and Laboratory Medicine,IFCC)推荐的质谱法测定糖化血红蛋白的参考方法中的应用价值。方法分别用两种特异性蛋白水解酶(GLU-C胞内蛋白酶和Lys-C胰蛋白酶)酶解血红蛋白后,进行SDS-PAGE电泳,衡量蛋白酶解的效率,再将消化后的血红蛋白进行质谱分析,测定标本中糖化血红蛋白的浓度。结果在相同的电泳条件下,Lys-C胰蛋白酶酶解血红蛋白的效率优于GLU-C;酶解后的血红蛋白标本经质谱方法分析可知,两种蛋白酶用于检测糖化血红蛋白浓度时,可以得到基本一致的结果,由两种方法绘制的标准曲线r2分别为0.929和0.998。结论在IFCC推荐的糖化血红的蛋白参考测量方法中,一直使用GLU-C胞内蛋白酶酶解血红蛋白,该研究尝试通过Lys-C胰蛋白酶的使用,降低整个实验成本。经结果分析,证实应用这两种特异性的蛋白酶检测糖化血红蛋白时,可以得到基本一致的结果,推荐使用文中所列方法将Lys-C胰蛋白酶作为酶解糖化血红蛋白的特异性蛋白酶。 Objective To explore the application value of Lys-C trypsin for the detection of glycosylated hemoglobin A1 (HbAlc) using the mass spectrometric method as reference method recommended by International Federation of Clinical Chemistry and Laboratory Medicine(IFCC). Methods Hemoglobin was enzymatically hydrolyzed by two kinds of proteolytic enzymes, inclu- ding intracel|ular protease GLU-C and Lys-C trypsin. SDS-PAGE was performed to measure the enzymatic hydrolysis efficiency, and after digestion of hemoglobin, mass spectrometry was used to determinate the HbAlc concentration. Results According to SDS-PAGE results, under the same electrophoresis conditions, the hydrolysis efficiency of Lys-C trypsin higher than GLU-C. Ac- cording to LTQ-Orbitrap Velos mass spectrometer analysis results, HbAlc concentrations in specimens treated with the two kinds of protease mitht be basically consistent, and r2 values of the two standard curves of the two methods were 0. 929 and 0. 998 re- spectively. Conclusion Treatment of Lys-C trypsin and GLU-C could acquire the same detection resulsts of HbAlc detected by ref- erence method recommended by IFCC, and Lys-C trypsin could replacing GLU--C for the detection of HbAlc.
出处 《国际检验医学杂志》 CAS 2013年第3期257-259,共3页 International Journal of Laboratory Medicine
基金 国家高技术研究发展计划(863计划)资助项目(2011AA02A116)
关键词 血红蛋白A 糖化 质谱分析法 Lys—C胰蛋白酶 GLU—C胞内蛋白酶 hemoglobin A, glycosylated mass spectrometry trypsin Lys-C endoproteinase GLU-C
  • 相关文献

参考文献12

  • 1Jeppsson JO, Kobold U, Barr J, et al. Approved IFCC reference method for the measurement of HbAlc in human blood[J]. Clin Chem Lab Med,2002,40(1):78-89.
  • 2UK Prospective Diabetes Study(UKPDS) Group. Intensive blood- glucose control with sulphonylureas or insulin compared with con- ventional treatment and risk of complications in patients with type 2 diabetes(UKPDS 33)[J]. Lancet,1998,352(9138) :837-853.
  • 3The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications' in insulin-dependent diabetes mellitus[J]. N Engl J Med,1993,329(14) :977-986.
  • 4Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China[J]. N Engl J Med, 2010, 362 (12) :1090- 1101.
  • 5American Diabets Association. Standards of medical care in diabe- te.s-2010[J].Diabetes Care, 2010,33 (Suppl 1 ) :s11-61.
  • 6邓兆享,彭杰雄,钟惠霞.糖化血红蛋白、空腹血糖和50g糖筛查对妊娠期糖尿病诊治的临床价值[J].国际检验医学杂志,2010,31(2):153-155. 被引量:20
  • 7赖基贤,江文庆,赖胜华,沈加贤.糖化血红蛋白在糖尿病诊断中的临床意义[J].临床医学,2011,31(2):53-54. 被引量:17
  • 8喻芳菊.三种糖尿病评估方法分析[J].实验与检验医学,2008,26(5):575-576. 被引量:14
  • 9International Federation of Clinical Chemistry and Laboratory Medicine, IFCC Scientific Division, Nordin G, et al. Recommenda- tion for term and measurement unit for "HbAlc"[J]. Clin Chem Lab Med,2007,45(8) :1081-1082.
  • 10宋智心,徐国宾,马怀安,王清涛.糖化血红蛋白测定的标准化现状[J].中华检验医学杂志,2012,35(6):497-500. 被引量:22

二级参考文献41

  • 1潘长玉,田慧,刘国良,李秀钧,傅祖植,陈家伟,暨亚洲糖尿病管理中国协作组.中国城市中心医院糖尿病健康管理调查[J].中华内分泌代谢杂志,2004,20(5):420-424. 被引量:193
  • 2赖基贤,林丽芬,沈加贤.血清果糖胺测定快速鉴别隐性2型糖尿病与应激性血糖增高(附82例报告)[J].临床医学,2003,23(5):49-50. 被引量:7
  • 3李继红,陈晓薇,朱锋.糖化血红蛋白测定在妊娠糖尿病诊断中的临床意义[J].中国妇幼保健,2006,21(1):111-113. 被引量:25
  • 4[2]Puavilai G,Chanprasertyotin S,Sriphrapradaeng.A.Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance:1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA).1998 WHO consueation criteria,and 1985 WHO criteria.World Health Organization[J],Diabetes Res Clin Pract,1999,44(1):21~26.
  • 5[3]Kuzuya T,Nakagawa S,Satoh J,et al.Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus[J].Diabetes Res Clin Pract,2002,55(1):65~85.
  • 6[4]American Diabetes Association.Report of the expert Committee on the Diagnosis and Classification of Diabetes Mellitus[J].Diabetes Care,1997,20:1183.
  • 7[5]Herdzik E,Safranow K,Ciechanowski K,et al.Comparison of ADA and WHO diagnostic criteria for diabetes diagnosis and other categories of glucose intolerance E[J].Pol Merkur Lekarski,2002,13(76):316.
  • 8[7]Rahlenbeck Sl.Monitoring diabetic control in developing countries:a review of glycated hemoglobin and fructosamine assays[J].Trop Doct,1998,28(1):9.
  • 9[8]Klonof DC.Serum fructosamine as a screening teat for type 2 diabetes[J].Diabetes Technol Ther,2000,2(4):537.
  • 10[9]Lindsey CC,Carter AW,Mangum S,et al.A prospective,randomized,multicentered controlled trial to compare the annual glycemic and quality outcomes of patients with diabetes mellitus monitored with weekly fructosamine testing versus usual care[J].Diabetes Technol Ther,2004,6(3):370.

共引文献82

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部